Literature DB >> 10837843

Alteration of the behavioral effects of nicotine by chronic caffeine exposure.

G Tanda1, S R Goldberg.   

Abstract

The prevalence of tobacco smoking and coffee drinking place nicotine and caffeine among the most used licit drugs in many societies and their consumption is often characterised by concurrent use. The pharmacological basis for any putative interaction between these drugs remains unclear. Some epidemiological reports support anecdotal evidence, which suggests that smokers consume caffeine to enhance the effects of nicotine. This paper reviews various aspects of the pharmacology of caffeine and nicotine, in humans and experimental animals, important for the understanding of the interactions between these drugs. In particular, recent experiments are reviewed in which chronic exposure to caffeine in the drinking water of rats facilitated acquisition of self-adminstration behavior, enhanced nicotine-induced increases in dopamine levels in the shell of the nucleus accumbens and altered the dopaminergic component of a nicotine discrimination. These studies provide evidence that the rewarding and subjective properties of nicotine can be changed by chronic caffeine exposure and indicate that caffeine exposure may be an important environmental factor in shaping and maintaining tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837843     DOI: 10.1016/s0091-3057(00)00234-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Factors associated with smokeless tobacco cessation in an Appalachian population.

Authors:  Ross M Kauffman; Amy K Ferketich; Alvin G Wee; Jennifer M Shultz; Patty Kuun; Mary Ellen Wewers
Journal:  Addict Behav       Date:  2008-01-11       Impact factor: 3.913

Review 2.  Caffeinated energy drinks--a growing problem.

Authors:  Chad J Reissig; Eric C Strain; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2008-09-21       Impact factor: 4.492

3.  Caffeine, a common active adulterant of cocaine, enhances the reinforcing effect of cocaine and its motivational value.

Authors:  José Pedro Prieto; Cecilia Scorza; Gian Pietro Serra; Valentina Perra; Martín Galvalisi; Juan Andrés Abin-Carriquiry; Giovanna Piras; Valentina Valentini
Journal:  Psychopharmacology (Berl)       Date:  2016-06-07       Impact factor: 4.530

4.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

5.  Effects of caffeine on persistence and reinstatement of nicotine-seeking behavior in rats: interaction with nicotine-associated cues.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

6.  Nicotine antagonizes caffeine- but not pentylenetetrazole-induced anxiogenic effect in mice.

Authors:  Hakan Kayir; I Tayfun Uzbay
Journal:  Psychopharmacology (Berl)       Date:  2005-07-01       Impact factor: 4.530

7.  Smoking among individuals with schizophrenia in Korea: gender differences.

Authors:  Sun S Kim; Sangkeun Chung; Jong-Il Park; Ae-Ja Jung; David Kalman; Douglas M Ziedonis
Journal:  Arch Psychiatr Nurs       Date:  2013-07-26       Impact factor: 2.218

8.  The effects of caffeine on L-arginine metabolism in the brain of rats.

Authors:  Ebru Ofluoglu; Hatice Pasaoglu; Aydin Pasaoglu
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

9.  Effects of caffeine on alcohol consumption and nicotine self-administration in rats.

Authors:  Amir H Rezvani; Hannah G Sexton; Joshua Johnson; Cori Wells; Karen Gordon; Edward D Levin
Journal:  Alcohol Clin Exp Res       Date:  2013-04-23       Impact factor: 3.455

10.  Effect of bupropion on nicotine self-administration in rats.

Authors:  Anthony S Rauhut; Nicole Neugebauer; Linda P Dwoskin; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2003-06-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.